Related Experiment Video
Updated: Dec 1, 2025

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI
Published on: May 24, 2022
Lentiviral Transduction for Optimal LSC/HSC Manipulation
1Section of Gastroenterology, Department of Medicine, Center for Regenerative Medicine (CReM), Boston University School of Medicine, Boston, MA, USA. gmostosl@bu.edu.
Efficiently transducing hematopoietic stem cells (HSCs) is crucial for gene therapy and research. HIV-lentiviruses offer superior transduction of quiescent HSCs, enabling long-term gene expression and engraftment for treating blood disorders.
Area of Science:
- Hematology
- Gene Therapy
- Molecular Biology
Background:
- Hematopoietic stem cell (HSC) transduction is vital for gene therapy and studying HSC function.
- Retroviruses have been used, but lentiviruses offer advantages for gene delivery.
Purpose of the Study:
- To describe the preparation of concentrated lentiviruses for HSC transduction.
- To achieve long-term engraftment and persistent gene transfer in HSCs.
Main Methods:
- Preparation of concentrated lentiviruses.
- Transduction of HSCs using lentiviral vectors.
- Assessment of long-term engraftment and gene expression.
Main Results:
- Lentiviral vectors enable efficient transduction of quiescent HSCs.
- Optimized lentivirus preparation and vector design are critical for consistent results.
- Achieved long-term engraftment with persistent transgene expression.
Conclusions:
- HIV-lentiviruses are superior for transducing quiescent HSCs compared to traditional retroviruses.
- This method facilitates reproducible gene transfer for HSC research and clinical applications.
- Successful gene transfer into HSCs holds promise for treating hematopoietic diseases.
More Related Videos
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019